Serotype | Burkina Faso | Senegal | Ghana | |||
---|---|---|---|---|---|---|
 | Age < 5 years | Age 5+ years | Age < 2 years | Age 2+ years | Age < 5 years | Age 5+ years |
1 | 3 (17%) | 18 (60%) | 10 (9%) | 90 (63%) | 2 (33%) | 51 (80%) |
2 | 3 (17%) | Â | 15 (14%) | 3 (2%) | Â | Â |
3 | Â | Â | 6 (5%) | 8 (6%) | 2 (33%) | 2 (3%) |
5 | 3 (17%) | Â | 23 (21%) | 8 (6%) | Â | Â |
6A | 5 (28%) | Â | 14 (13%)* | 13 (9%)* | Â | 1 (2%) |
6B | 1 (6%) | Â | Â | Â | Â | Â |
7/7F | Â | 1 (3%) | Â | Â | Â | 1 (2%) |
8 | Â | Â | Â | Â | Â | 4 (6%) |
9 | Â | Â | 6 (5%) | 2 (1%) | Â | Â |
10/10F | 1 (6%) | Â | Â | Â | Â | 1 (2%) |
12A | Â | 1 (3%) | 9 (8%)* | 6 (4%)* | Â | Â |
12B | Â | 1 (3%) | Â | Â | Â | Â |
12F | Â | Â | Â | Â | Â | 2 (3%) |
14 | Â | 2 (7%) | 5 (5%) | 2 (1%) | 2 (33%) | 1 (2%) |
18 | Â | Â | 4 (4%) | 2 (1%) | Â | Â |
19A | Â | 1 (3%) | 4 (4%)* | 4 (3%)* | Â | Â |
19F | Â | 1 (3%) | Â | Â | Â | Â |
21 | 1 (6%) | Â | Â | Â | Â | Â |
23 | Â | Â | 14 (13%) | 5 (3%) | Â | Â |
24A | 1 (6%) | Â | Â | Â | Â | Â |
25A | Â | 2 (7%) | Â | Â | Â | Â |
25F | Â | 2 (7%) | Â | Â | Â | Â |
38 | Â | Â | Â | Â | Â | 1 (2%) |
NT | Â | 1 (3%) | Â | Â | Â | Â |
Total | 18 (100%) | 30 (100%) | 110 (100%) | 143 | 6 (100%) | 64 (100%) |